BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

FDA approves Sirturo for treating children with pulmonary multidrug-resistant TB

By

The Janssen Pharmaceutical Companies of Johnson & Johnson announced this week that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline)....

Malaria: FDA approves artesunate for injection to treat severe forms

By

By NewsDesk  @infectiousdiseasenews Frederick, Maryland company specializing in treatments for rare and neglected tropical diseases, Amivas, announced Tuesday that Artesunate for Injection 110 mg, powder...

First patient dosed in pivotal Phase 3 trial for novel antifungal for both treatment and prevention of serious fungal infections

By

Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma announced...

Anti-malaria drug, chloroquine, studied to determine ability to protect health workers from COVID-19

By

With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies for COVID-19. The group, called the COVID-19...

Acinetobacter baumannii infections: Global Phase 3 ATTACK trial of Sulbactam-Durlobactam

By

By NewsDesk  @infectiousdiseasenews Commercial stage biopharmaceutical company, Zai Lab Limited, announced today dosing of the first Chinese patient in the global ATTACK (Acinetobacter Treatment Trial...

COVID-19

Hydroxychloroquine and azithromycin to treat COVID-19 clinical trial begins

By

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019...

Senicapoc, a drug developed to treat sickle cell anemia, being studied for COVID-19

By

Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19. UC Davis Health researchers provided one of those repurposed drugs, senicapoc,...

COVID-19 treatment: Feds announce the allocation plan for the drug remdesivir

By

On Saturday, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) announced the allocation plan for the drug remdesivir. The allocation...

COVID-19: New triple antiviral drug combination shows early promise for treatment in phase 2 randomized trial

By

A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more effective at reducing the duration...

Antibiotics: RECARBRIO vs. PIP/TAZ Phase 3 clinical trial results

By

Merck announced results from RESTORE-IMI 2, a randomized, controlled, double-blind Phase 3 clinical trial evaluating RECARBRIO™ (imipenem, cilastatin, and relebactam) for the treatment of adults with...